Zumutor Biologics
Woburn
About Zumutor Biologics
Zumutor is a leading Immuno-Oncology company in the space of targeted NK cell therapeutics. They have two proprietary Antibody Engineering Platforms to develop novel immunotherapies that target innate immunity and regulate the tumor microenvironment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $47.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: zumutor.com
Industries & Categories
Biotechnology, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/zumutor-biologics-57220 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.